Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetCool ACS – Metformin “Cooling” Effect on Metformin-naive Patients with Acute Coronary Syndrome Undergoing PCI
2020-004962-21Phase 3Active
- Sponsor
- Military Institute of Medicine – National Research Institute
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in acute coronary syndrome (ACS) and coronary arteriosclerosis, sponsored by Military Institute of Medicine – National Research Institute. Primary endpoint: Unplanned coronary revascularization. Started Dec 2020; status: active.
02
Drugs
metformin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2020-004962-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004962-21.